


CD37

Anti-CD37 Products
- Human Anti-CD37 Recombinant Antibody scFv Fragment (TAB-0272CL-S(P)) (TAB-0272CL-S(P))
-
- Type: Chimeric (mouse/human)
- Application: ELISA, WB
- Human Anti-CD37 Recombinant Antibody scFv Fragment (TAB-0273CL-S(P)) (TAB-0273CL-S(P))
-
- Type: Chimeric (mouse/human)
- Application: Block
- Human Anti-CD37 Recombinant Antibody Fab Fragment (TAB-0272CL-F(E)) (TAB-0272CL-F(E))
-
- Type: Chimeric (mouse/human)
- Application: ELISA, WB
- Human Anti-CD37 Recombinant Antibody Fab Fragment (TAB-0273CL-F(E)) (TAB-0273CL-F(E))
-
- Type: Chimeric (mouse/human)
- Application: Block
- Mouse Anti-CD37 Recombinant Antibody (clone 3C9) (MOB-0492CT)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, IF, WB
- Human Anti-CD37 Recombinant Antibody (TAB-0272CL) (TAB-0272CL)
-
- Type: Chimeric (mouse/human)
- Application: ELISA, WB
- Human Anti-CD37 Recombinant Antibody (TAB-0273CL) (TAB-0273CL)
-
- Type: Chimeric (mouse/human)
- Application: Block
- Human Anti-CD37 Recombinant Antibody (HPAB-1045-FY) (HPAB-1045-FY)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: FC, ELISA
- Human Anti-CD37 Recombinant Antibody (HPAB-1046-FY) (HPAB-1046-FY)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: FC, ELISA
- Human Anti-CD37 Recombinant Antibody (HPAB-1047-FY) (HPAB-1047-FY)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: ELISA, FC, IHC
- Mouse Anti-CD37 Recombinant Antibody (HPAB-0159-FY) (HPAB-0159-FY)
-
- Species Reactivity: Human
- Type: Mouse IgG2a
- Application: Activ, Depletion, FuncS, Inhib
- Mouse Anti-CD37 Recombinant Antibody (HPAB-0163-FY) (HPAB-0163-FY)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC, Inhib, FuncS
- Mouse Anti-CD37 Recombinant Antibody (HPAB-0164-FY) (HPAB-0164-FY)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC, Inhib, CDC, FuncS
- Rabbit Anti-CD37 Recombinant Antibody (VS-0723-WK238) (VS-0723-WK238)
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: ELISA, FC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b, κ
- Application: FC, IF, IHC
- Human Anti-CD37 Recombinant Antibody (clone G28-1) (FAMAB-1051CQ)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: Depletion
- Mouse Anti-CD37 Recombinant Antibody (clone WR17) (FAMAB-1052CQ)
-
- Species Reactivity: Human
- Type: Mouse IgG2a
- Application: FC
- Mouse Anti-CD37 Recombinant Antibody (HPAB-0901-WJ) (HPAB-0901-WJ)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: FC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Application: ELISA, IHC, FC, IP, IF, FuncS
- Human Anti-CD37 Recombinant Antibody (clone A2) (HPAB-AP033-YC)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: FuncS
- Human Anti-CD37 Recombinant Antibody (clone B2) (HPAB-AP034-YC)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: FC, IF, IHC, ELISA
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: FC, IF, IHC, ELISA
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: FC, IF, IHC, ELISA
-
- Species Reactivity: Human
- Type: Mouse IgG2b
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Human Anti-CD37 Recombinant Antibody (clone Naratuximab) (VS-0723-WK47)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1
- Application: FC
- Human Anti-CD37 Recombinant Antibody (clone MB-1) (FAMAB-1053CQ)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: ICC, IHC-P, WB, FC
- Human Anti-CD37 Antibody (clone G28-1), mRNA (FAMAB-1051CQ-mRNA)
-
- Species Reactivity: Human
- Mouse Anti-CD37 Antibody (clone WR17), mRNA (FAMAB-1052CQ-mRNA)
-
- Species Reactivity: Human
- Human Anti-CD37 Antibody (clone MB-1), mRNA (FAMAB-1053CQ-mRNA)
-
- Species Reactivity: Human
-
- Species Reactivity: Human, Mouse
- Type: Mouse IgG
- Application: IF, ELISA
- Mouse Anti-CD37 Recombinant Antibody (clone 2B8) (VS3-XY281)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB, ICC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b, κ
- Application: WB, IP, IF, IHC, ELISA
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: VH - V-kappa - CH2 - CH3
- Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
- Mouse Anti-CD37 Recombinant Antibody (HPAB-0004-SJF) (HPAB-0004-SJF)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, IHC, FuncS
- Mouse Anti-CD37 Recombinant Antibody (clone A0) (HPAB-0006-SJF)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FACS, FuncS
- Human Anti-CD37 Recombinant Antibody (HPAB-0009-SJF) (HPAB-0009-SJF)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1
- Application: FuncS
- Mouse Anti-CD37 Recombinant Antibody; scFv Fragment (HPAB-0004-SJF-S(P)) (HPAB-0004-SJF-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, IHC, FuncS
- Mouse Anti-CD37 Recombinant Antibody (clone A0); scFv Fragment (HPAB-0006-SJF-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FACS, FuncS
- Human Anti-CD37 Recombinant Antibody; Fab Fragment (HPAB-1047-FY-F(E)) (HPAB-1047-FY-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: FC, ELISA
- Human Anti-CD37 Recombinant Antibody; scFv Fragment (HPAB-1045-FY-S(P)) (HPAB-1045-FY-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human scFv
- Application: FC, ELISA
- Human Anti-CD37 Recombinant Antibody; scFv Fragment (HPAB-1046-FY-S(P)) (HPAB-1046-FY-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human scFv
- Application: FC, ELISA
- Human Anti-CD37 Recombinant Antibody; scFv Fragment (HPAB-1047-FY-S(P)) (HPAB-1047-FY-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human scFv
- Application: FC, ELISA
- Human Anti-CD37 Recombinant Antibody scFv Fragment (HPAB-0009-SJF-S(P)) (HPAB-0009-SJF-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: FuncS
- Mouse Anti-CD37 Recombinant Antibody; Fab Fragment (HPAB-0004-SJF-F(E)) (HPAB-0004-SJF-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, IHC, FuncS
- Mouse Anti-CD37 Recombinant Antibody (clone A0); Fab Fragment (HPAB-0006-SJF-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FACS, FuncS
- Human Anti-CD37 Recombinant Antibody Fab Fragment (HPAB-0009-SJF-F(E)) (HPAB-0009-SJF-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: FuncS
- Human Anti-CD37 Recombinant Antibody (clone A2); scFv Fragment (HPAB-AP033-YC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: FuncS
- Human Anti-CD37 Recombinant Antibody (clone B2); scFv Fragment (HPAB-AP034-YC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: FuncS
- Human Anti-CD37 Recombinant Antibody (clone A2); Fab Fragment (HPAB-AP033-YC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: FuncS
- Mouse Anti-CD37 Recombinant Antibody; scFv Fragment (HPAB-0159-FY-S(P)) (HPAB-0159-FY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Activ, Depletion, FuncS, Inhib
- Mouse Anti-CD37 Recombinant Antibody; scFv Fragment (HPAB-0163-FY-S(P)) (HPAB-0163-FY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC, Inhib
- Mouse Anti-CD37 Recombinant Antibody; scFv Fragment (HPAB-0164-FY-S(P)) (HPAB-0164-FY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC, Inhib
- Mouse Anti-CD37 Recombinant Antibody; Fab Fragment (HPAB-0159-FY-F(E)) (HPAB-0159-FY-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: Activ, Depletion, FuncS, Inhib
- Mouse Anti-CD37 Recombinant Antibody; Fab Fragment (HPAB-0163-FY-F(E)) (HPAB-0163-FY-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FC, Inhib
- Mouse Anti-CD37 Recombinant Antibody; Fab Fragment (HPAB-0164-FY-F(E)) (HPAB-0164-FY-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FC, Inhib
- Mouse Anti-CD37 Recombinant Antibody scFv Fragment (HPAB-0901-WJ-S(P)) (HPAB-0901-WJ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
- Human Anti-CD37 Recombinant Antibody (clone B2); Fab Fragment (HPAB-AP034-YC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: FuncS
- Mouse Anti-CD37 Recombinant Antibody Fab Fragment (HPAB-0901-WJ-F(E)) (HPAB-0901-WJ-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FC
-
- Species Reactivity: Human
- Type: Antibody hexamer
- Application: FC, Inhib, CDC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Antibody hexamer
- Application: CDC
- Human Anti-CD37 Recombinant Antibody; Fab Fragment (HPAB-1045-FY-F(E)) (HPAB-1045-FY-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: FC, ELISA
- Human Anti-CD37 Recombinant Antibody; Fab Fragment (HPAB-1046-FY-F(E)) (HPAB-1046-FY-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: FC, ELISA
- Anti-Human CD37 Recombinant Antibody (Lilotomab) (TAB-467CQ)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: IgG1, κ
- Application: ELISA, IHC, FC, IP, IF, FuncS
- Anti-CD37 (K7153A)-SMCC-DM1 ADC (IMGN529) (ADC-L019)
-
- Target: CD37
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto- 1-oxopropyl)maytansine)
-
- Antibody Host: Mouse
- Antibody Reactivity: Human
- Human Anti-CD37 (clone chHH1.1) scFv-Fc Chimera (VS-0125-FY21)
-
- Species Reactivity: Human
- Type: Human IgG1, scFv-Fc
- Application: Inhib
- Anti-CD37 (K7153A)-SMCC-DM1 ADC (ADC-064LCT)
-
- Target: CD37
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD37-SMCC-maytansinoid ADC (ADC-016LZY)
-
- Target: CD37
- Linker: SMCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: maytansinoid
- Anti-CD37-vc-MMAE ADC (ADC-037LZY)
-
- Target: CD37
- Linker: VC (Valine-citrulline)
- Drug: MMAE (monomethyl auristatin E)
-
- Target: CD37
- Linker: mc-val-cit-PABC (cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
-
- Species Reactivity: Human
- Type: Mouse IgG1, kappa
- Application: FC
-
- Derivation: Mouse
- Species Reactivity: Human, Mouse
- Type: Mouse IgG
- Application: IF, ICC, ELISA
-
- Species Reactivity: Human
- Target: CD37
- Host Animal: Mouse
- Application: ELISA, FC, Neut, Cell-uptake
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs offers high-quality, comprehensive recombinant antibodies specifically targeting CD37, designed to meet the needs of biomedical researchers and institutions. Our antibodies are meticulously developed to ensure optimal specificity and performance in various applications. With a commitment to advancing research, we provide reliable tools that empower scientists to make significant discoveries in their respective fields, enhancing the overall impact of their work.
CD37: A Significant Target in Hematological Malignancies
CD37 is a transmembrane protein expressed on the surface of various immune cells. It plays a crucial role in regulating immune responses and cell signaling. In the context of diseases, CD37 is of significant interest, particularly in hematological malignancies such as chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). The abnormal expression of CD37 in these cancers makes it an attractive therapeutic target. Clinical research on targeting CD37 has shown great potential. For instance, monoclonal antibodies or antibody-drug conjugates directed against CD37 have demonstrated efficacy in clinical trials. They can selectively target and kill cancer cells expressing CD37, offering a novel treatment approach with reduced side effects compared to conventional therapies. Moreover, understanding the role of CD37 in disease progression and its interaction with the tumor microenvironment could lead to the development of more effective combination therapies, improving patient prognosis and quality of life.
Alternative Names
CD37 molecule, GP52-40, TSPAN26
Background
The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to be complex with integrins and other transmembrane 4 superfamily proteins. It may play a role in T-cell-B-cell interactions. Alternate splicing results in multiple transcript variants encoding different isoforms.
CD markers
Intracellular, Membrane (different isoforms)
Cell type enhanced (B-cells, dendritic cells, NK-cells, T-cells, monocytes, Langerhans cells, Hofbauer cells, Macrophages)
Low immune cell specificity
Cell line enhanced (Daudi, HMC-1, RPMI-8226, THP-1, U-698, U-937)
Interacts with SCIMP.
Anti-CD37 rAb Products
The high-quality anti-CD37 recombinant antibody products are furnished to accelerate the research and discovery of drugs associated with the target CD37.
Cat. No. | Product Name | Target Species | Host Species | Applications |
TAB-904 | Anti-Human CD37 Recombinant Antibody (Otlertuzumab) | Human | Human | ELISA; IP; FC; FuncS; Neut; IF; ICC |
TAB-0272CL-S(P) | Anti-Human CD37 Recombinant Antibody scFv Fragment (chHH1.1) | Human | Human | ELISA; WB |
HPAB-0159-FY | Mouse Anti-CD37 Recombinant Antibody (HPAB-0159-FY) | Human | Mouse | Activ; Depletion; FuncS |
HPAB-AP033-YC | Human Anti-CD37 Recombinant Antibody (clone A2) | Human | Human | FuncS |
HPAB-1047-FY | Human Anti-CD37 Recombinant Antibody | Human | Human | ELISA; FC; IHC |
Creative Quality Control
To meet the demands of our customers regarding antibody quality, a strict quality management system has been set up to guarantee our product quality and assist customers in conducting research work more effectively.
Fig.1 SDS-PAGE analysis of anti-CD37 antibody (Cat#
TAB-0272CL-S(P), Creative Biolabs).
Fig.2 SEC-HPLC analysis of anti-CD37 antibody (Cat#
TAB-0272CL-S(P), Creative Biolabs).
Customer Reviews

Anti-Human CD37 Recombinant Antibody scFv Fragment (chHH1.1) (Cat#: TAB-0272CL-S(P))

Anti-Human CD37 Recombinant Antibody (Otlertuzumab) (Cat#: TAB-904)

Human Anti-CD37 Recombinant Antibody (Cat#: HPAB-1047-FY)
Anti-CD37 Recombinant Antibody Production
Our serum-free mammalian cell expression platform provides a one-stop service, which extends from gene synthesis to the production of high-quality milligram recombinant antibodies. We have over 5 years of experience in optimizing processes related to expression vectors, cloning systems, and high-yield mammalian cell lines, and can supply customers with high-quality and stable antibodies.
Featured Anti-CD37 Recombinant Antibody Production Platforms
Fig.3 Milligram-scale recombinant antibody production.
Fig.4 Gram-scale recombinant antibody production.
rAb Modalities
Creative Biolabs is determined to supply researchers with the most all-round and state-of-the-art high-quality recombinant antibodies in diverse formats. The antibody formats comprise, without limitation, full length, scFv, scFv-Fc, scFv-CH3, sc-Fab, full length with various Fc isotypes, etc. Our products are supported by superior custom engineering services in accordance with your specific requirements.
Fig.5 Full Length Anti-CD37 Recombinant Antibody Production and Modalities
Drug Information Targeting CD37
Table 1. Therapeutic approaches targeting CD37 in clinical development.
Research phase | Company | Classification | Indications | Details |
Phase II | Debiopharm | Drug Conjugates | Chronic lymphocytic leukemia; Cancer | It is an antibody-drug conjugate (ADC) originated at ImmunoGen consisting of the CD37-binding, humanized IgG1antibody K7153A attached to the maytansinoid DM-1 via the non-cleavable thioether linker SMCC. |
Phase II |
Abbott Aptevo Therapeutics |
Biologics |
Autoimmune disease; Chronic lymphocytic leukemia |
It is a CD37-targeted therapy in phase II clinical trials at Aptevo Therapeutics (spun-out from Emergent Biosolutions) for the treatment of peripheral T-cell lymphoma. Phase I/II clinical trials are also underway for the treatment of chronic lymphocytic leukemia (CLL). |
If you need more information regarding our anti-CD37 recombinant antibody products, feel free to reach out to us at any time. Our team is eager to assist you with any questions or inquiries, and we look forward to developing a mutually beneficial collaboration that advances your research efforts.